美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Invesco Nasdaq Biotechnology ETF

34.69

-0.4365-1.24%

盤後：34.720.0307+0.09%19:30 EDT

成交量：2.55萬

成交額：88.53萬

市值：9,643.63萬

市盈率：- -

高：35.13

開：35.13

低：34.63

收：35.13

52周最高：36.84

52周最低：23.42

股本：278.00萬

流通股本：278.00萬

量比：1.14

換手率：0.92%

股息：0.26

股息率：0.74%

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

邁普醫學：可吸收止血流體明膠作為第三類醫療器械進入臨床試驗

創新藥概念午後拉升，亞太藥業直線漲停，百普塞斯升逾10%，萬邦醫藥、皓元醫藥升逾6%。

諾華DM1藥物III期臨床試驗未達到主要終點

酶的戰爭：一場或將重塑全球創新藥競爭格局的「皮下革命」

富國銀行上調安進目標價至435美元

上半年創新藥冰火兩重天：百濟神州一款藥賣了超160億元，六成藥企還在求生

每日经济新闻

石藥集團(01093)：SYH2085片用於治療成人單純性流感的II期臨床試驗在中國正式啓動

石藥集團：SYH2085片II期臨床試驗在中國正式啓動

繼諾華之後，諾和諾德(NVO.US)終止兩項心血管臨床試驗

恒瑞醫藥(01276)：SHR-1179注射液獲得藥物臨床試驗批准通知書

榮昌生物：關於參加科創板2026年半年度創新藥行業集體業績説明會的公告

证券日报网

諾和諾德再次暫停了其實驗性心臟病藥物的兩項臨床試驗，進一步打擊了該藥的發展前景。

艾迪藥業：關於參加科創板2026年半年度創新藥行業集體業績説明會的公告

证券日报网

恒瑞醫藥(600276.SH)子公司HRS-1597片獲批開展臨床試驗

智飛生物(300122.SZ)：重組輪狀病毒亞單位疫苗(大腸桿菌)獲得臨床試驗批准

恒瑞醫藥：子公司HRS-1597片獲臨床試驗批准

恒瑞醫藥：HRS-6209膠囊、HRS-4508片獲臨床試驗批准

南方财经网

華蘭疫苗(301207.SZ)：新型流感病毒mRNA疫苗臨床試驗獲批目前國內尚無流感病毒mRNA疫苗產品獲批上市

華蘭疫苗(301207.SZ)：新型流感病毒mRNA疫苗臨床試驗獲批目前國內尚無流感病毒mRNA疫苗產品獲批上市

智飛生物：重組輪狀病毒亞單位疫苗獲臨床試驗批准

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hant/stock/IBBQ/news?page=10"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IBBQ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBBQ\",,,,,undefined,":{"symbol":"IBBQ","market":"US","secType":"STK","nameCN":"Invesco Nasdaq Biotechnology ETF","latestPrice":34.6893,"timestamp":1789761600000,"preClose":35.1258,"halted":0,"volume":25488,"hourTrading":{"tag":"盘后","latestPrice":34.72,"preClose":34.6893,"latestTime":"19:30 EDT","volume":12,"amount":417.156504,"timestamp":1789774205753,"change":0.0307,"changeRate":0.000885,"amplitude":0.020199},"delay":0,"changeRate":-0.012426763233862154,"floatShares":2780001,"shares":2780001,"eps":0,"marketStatus":"盤後交易","change":-0.4365,"latestTime":"09-18 19:42:49 EDT","open":35.13,"high":35.13,"low":34.6296,"amount":885294.380736,"amplitude":0.014246,"askPrice":52.1,"askSize":100,"bidPrice":34.38,"bidSize":8700,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1789776000000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":35.1258,"sharesOutstanding":2520001,"nav":34.34966,"aum":95492089.14966,"dividendRate":0.007406,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":34.72,"preClose":34.6893,"latestTime":"19:30 EDT","volume":12,"amount":417.156504,"timestamp":1789774205753,"change":0.0307,"changeRate":0.000885,"amplitude":0.020199},"volumeRatio":1.139495,"impliedVol":0.0457,"impliedVolPercentile":0.0199},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBBQ\",,,,,undefined,":{"symbol":"IBBQ","floatShares":2780001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.139495,"shares":2780001,"dividePrice":0.2569,"high":35.13,"amplitude":0.014246,"preClose":35.1258,"low":34.6296,"week52Low":23.42,"pbRate":"--","week52High":36.84,"institutionHeld":0,"latestPrice":34.6893,"committee":0.977273,"eps":0,"divideRate":0.007406,"volume":25488,"delay":0,"ttmEps":0,"open":35.13,"prevYearClose":28.3962,"prevWeekClose":34.472,"prevMonthClose":35.4742,"prevQuarterClose":32.66,"fiveDayClose":34.472,"twentyDayClose":35.8,"sixtyDayClose":31.2119},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBBQ\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"IBBQ","amount":0.03422,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-26"},{"date":"2026-03-23","symbol":"IBBQ","amount":0.03609,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2025-12-22","symbol":"IBBQ","amount":0.0906,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2025-09-22","symbol":"IBBQ","amount":0.09576,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"},{"date":"2025-06-23","symbol":"IBBQ","amount":0.0287,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-27","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBBQ\",market:\"US\",,,undefined,":[{"executeDate":"2021-09-20","recordDate":"2021-09-21","paymentDate":"2021-09-30","value":0.04324,"currency":"USD"},{"executeDate":"2021-12-20","recordDate":"2021-12-21","paymentDate":"2021-12-31","value":0.10511,"currency":"USD"},{"executeDate":"2022-03-21","recordDate":"2022-03-22","paymentDate":"2022-03-31","value":0.03778,"currency":"USD"},{"executeDate":"2022-06-21","recordDate":"2022-06-22","paymentDate":"2022-06-30","value":0.04264,"currency":"USD"},{"executeDate":"2022-09-19","recordDate":"2022-09-20","paymentDate":"2022-09-23","value":0.03769,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBBQ\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBBQ\",pageSize:20,pageCount:10,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2665332349","title":"邁普醫學：可吸收止血流體明膠作為第三類醫療器械進入臨床試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=2665332349","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665332349?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 16:14","pubTimestamp":1788855283,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MDEV","PSYK","LNGR","RSPH","MDTX","IEIH","BMED","GDOC","IBBQ","HART","LGHT","MEDX","PTH","AGNG","IBBJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665342986","title":"創新藥概念午後拉升，亞太藥業直線漲停，百普塞斯升逾10%，萬邦醫藥、皓元醫藥升逾6%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2665342986","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665342986?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 13:44","pubTimestamp":1788846270,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MEDX","LNGR","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665342373","title":"諾華DM1藥物III期臨床試驗未達到主要終點","url":"https://stock-news.laohu8.com/highlight/detail?id=2665342373","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665342373?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 13:31","pubTimestamp":1788845477,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["IE0002141913.USD","IE00BFTCPJ56.SGD","LU0208291251.USD","BK4588","IE00B2B36J28.USD","MDTX","IBBQ","BK4585","IE00B4R5TH58.HKD","BMED","MEDX","PPH","IE00BJT1NW94.SGD","LU0320765489.SGD","IBBJ","NVS","PSYK","LU0211331839.USD","BK4532","IE00BJJMRZ35.SGD","BK4007","LU0070302665.USD","BK4578","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665341826","title":"酶的戰爭：一場或將重塑全球創新藥競爭格局的「皮下革命」","url":"https://stock-news.laohu8.com/highlight/detail?id=2665341826","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665341826?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 11:13","pubTimestamp":1788837196,"startTime":"0","endTime":"0","summary":"算上诺华，已有10家全球制药巨头为ALT-B4签下许可协议。有意思的地方在于：这些交易里没有一款新药。2025年9月，默沙东的Keytruda Qlex获FDA批准，成为首个使用ALT-B4的商业化产品。第一张牌，宝济药业的“国产first”。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1788753577275365008","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["MEDX","IBBQ","06978","BK1161","BK1574","LNGR","159992"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665349003","title":"富國銀行上調安進目標價至435美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2665349003","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665349003?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 11:12","pubTimestamp":1788837128,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["IE00BJJMRZ35.SGD","UDN","LU0058720904.USD","LU2112291526.USD","LU0289739699.SGD","LU0868494617.USD","IBBQ","IE00BJT1NW94.SGD","LU2468319806.SGD","PBE","BK4588","LU0122379950.USD","TBXU","IE00B4R5TH58.HKD","AMGN","UUP","IE00B2B36J28.USD","LU0109394709.USD","LU1571399168.USD","LU1061106388.HKD","IE0002141913.USD","SG9999001440.SGD","LU1057294990.SGD","BK4585","IE00BFTCPJ56.SGD","IBB","BK4533","BIB","BK4599","IE0009355771.USD","LU1023059063.AUD","LU2242646821.SGD","BBH","LU2089984988.USD","LU1983299246.USD","BK4581","LU0889565916.HKD","BK4534","LU2242652126.USD","PGF","LU0320765992.SGD","BK4566","PJP","BK4582","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665311078","title":"上半年創新藥冰火兩重天：百濟神州一款藥賣了超160億元，六成藥企還在求生","url":"https://stock-news.laohu8.com/highlight/detail?id=2665311078","media":"每日经济新闻","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665311078?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 20:39","pubTimestamp":1788784781,"startTime":"0","endTime":"0","summary":"2026年上半年财报季收官，中国创新药产业交出了一份分水岭式的答卷。行业正在告别“烧钱讲故事”的阶段，走向“赚钱才是硬道理”的价值兑现期。这种转变并非行业普遍现象，而是由商业化放量、出海授权爆发、资金来源多元化三重力量共同推动的分化。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609073866904351.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609073866904351.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4585","IBBQ","BK4526","BK4588","LU0228659784.USD","LU0588546209.SGD","LNGR","ONC","BK1500","BK1583","LU0307460666.USD","MEDX","06160","BK1161","688235","BK4139","LU1303224171.USD","LU2328871848.SGD","BK1574","LU0828237510.HKD","BK1588","LU1251922891.USD","LU1719994722.HKD","LU1969619763.USD","LU1770034418.SGD","KURE","159992","06978","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665319978","title":"石藥集團(01093)：SYH2085片用於治療成人單純性流感的II期臨床試驗在中國正式啓動","url":"https://stock-news.laohu8.com/highlight/detail?id=2665319978","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665319978?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 19:30","pubTimestamp":1788780616,"startTime":"0","endTime":"0","summary":"智通财经APP讯，石药集团 发布公告，集团开发的SYH2085片用于治疗成人无并发症的单纯性流行性感冒的II期临床试验已于中国首家中心正式启动。此前，集团已于2025年12月获中国国家药品监督管理局就该产品签发的《药物临床试验批准通知书》。本次启动的该产品临床试验为多中心、随机、双盲、安慰剂对照的II期临床研究，旨在评价该产品治疗中国成人无并发症的单纯性流行性感冒参与者中的有效性及安全性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1492970.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0315179316.USD","LU0140636845.USD","LU1807302812.USD","LU0880133367.SGD","LU0067412154.USD","IE00B031HY20.USD","LU1993786604.SGD","01093","LU1328277881.USD","PSYK","IE0008368742.USD","LU1951186391.HKD","IE00BZ08YT58.USD","MDTX","LU0326950275.SGD","IE00B5MMRT66.SGD","IBBJ","BK1521","BK1191","BMED","LU0314109678.HKD","IE0008369823.USD","SG9999004220.SGD","LU1226287875.USD","IE00B543WZ88.USD","HK0000165453.HKD","LU1226288253.USD","BK1515","LU2039709279.SGD","IBBQ","IE00BZ08YR35.GBP","LU0072913022.USD","LU1226287529.USD","LU1008478684.HKD","LU1152091168.USD","LU1960683339.HKD","LU0501845795.SGD","LU1152091754.HKD","IE00BZ08YS42.EUR","KURE","LU1226288170.HKD","LU1813983027.USD","LU1226287792.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665319936","title":"石藥集團：SYH2085片II期臨床試驗在中國正式啓動","url":"https://stock-news.laohu8.com/highlight/detail?id=2665319936","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665319936?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 19:28","pubTimestamp":1788780492,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IBBQ","MDTX","PSYK","BMED","IBBJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665831989","title":"繼諾華之後，諾和諾德(NVO.US)終止兩項心血管臨床試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=2665831989","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665831989?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 19:10","pubTimestamp":1788779458,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00B2B36J28.USD","LU0070302665.USD","IBBJ","IBBQ","MDTX","LU0208291251.USD","BGIA","LU0320765489.SGD","IE00BJT1NW94.SGD","LU0211331839.USD","PPH","BK4588","NVS","BK4585","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","PSYK","BK4578","MEDX","IE0002141913.USD","BMED","IE0009355771.USD","BK4007","BK4532","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665031616","title":"恒瑞醫藥(01276)：SHR-1179注射液獲得藥物臨床試驗批准通知書","url":"https://stock-news.laohu8.com/highlight/detail?id=2665031616","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665031616?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 18:49","pubTimestamp":1788778166,"startTime":"0","endTime":"0","summary":"智通财经APP讯，恒瑞医药(01276)发布公告，近日，江苏恒瑞医药股份有限公司(以下简称“公司”)子公司广东恒瑞医药有限公司收到国家药品监督管理局(以下简称“国家药监局”)核准签发关于 SHR-1179 注射液的《药物临床试验批准通知书》，将于近期开展临床试验。SHR-1179 注射液是公司自主研发的治疗用 1 类生物制品，拟用于体重管理适应症，国内外暂无相同靶点药物获批上市。截至目前，SHR-1179 注射液相关项目累计研发投入约2,420万元(未经审计)。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1492927.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1580142542.USD","PSYK","BK1191","IBBJ","LU1146622755.USD","LU2543165471.USD","BK0183","01276","LU2097828714.EUR","BK0028","LU0405327148.USD","LU2097828557.USD","LU2148510915.USD","LU2097828474.EUR","600276","BK0196","BMED","LU2488822045.USD","LU2097828805.USD","BK0188","LU1781817850.SGD","LU1997245094.SGD","LU2097828631.EUR","MDTX","IBBQ","BK0060","LU1255011170.USD","LU1969619763.USD","LU2495084118.USD","LU1064131003.USD","LU1328615791.USD","BK0012","LU1820825898.SGD","LU1023057109.AUD","BK0239","LU1997245177.USD","LU0359201612.USD","LU0359201885.HKD","LU0359202008.SGD","LU2580892862.HKD","LU1655091616.SGD","LU1997244956.HKD","LU2328871848.SGD","LU2289578879.USD","LU2580892789.USD","LU0405327494.USD","LU1064130708.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665731933","title":"榮昌生物：關於參加科創板2026年半年度創新藥行業集體業績説明會的公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2665731933","media":"证券日报网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665731933?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 18:43","pubTimestamp":1788777780,"startTime":"0","endTime":"0","summary":"证券日报网讯9月7日，荣昌生物发布公告称，公司计划于2026年9月16日15：00-17：00参加2026年半年度科创板创新药行业集体业绩说明会，就投资者关心的问题进行交流。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/hk/2026-09-07/doc-iniqyzxs9619866.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/hk/2026-09-07/doc-iniqyzxs9619866.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU2328871848.SGD","LNGR","KSTR","688331","IBBQ","LU2148510915.USD","09995","LU1969619763.USD","BK1574","06978","LU2488822045.USD","LU1064130708.USD","159992","BK1583","BK0239","BK1161","MEDX","LU1064131003.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665315689","title":"諾和諾德再次暫停了其實驗性心臟病藥物的兩項臨床試驗，進一步打擊了該藥的發展前景。","url":"https://stock-news.laohu8.com/highlight/detail?id=2665315689","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665315689?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 18:02","pubTimestamp":1788775332,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MDTX","BGIA","PSYK","IBBJ","IBBQ","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665319730","title":"艾迪藥業：關於參加科創板2026年半年度創新藥行業集體業績説明會的公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2665319730","media":"证券日报网","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665319730?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 18:01","pubTimestamp":1788775260,"startTime":"0","endTime":"0","summary":"证券日报网讯9月7日，艾迪药业发布公告称，公司计划于2026年9月16日15：00-17：00参与由上海证券交易所主办的科创板2026年半年度创新药行业集体业绩说明会。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-09-07/doc-iniqyzxw5472550.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-09-07/doc-iniqyzxw5472550.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IBBQ","BK1574","159992","MEDX","688488","06978","LNGR","KSTR","BK1161","BK0262"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665313519","title":"恒瑞醫藥(600276.SH)子公司HRS-1597片獲批開展臨床試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=2665313519","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665313519?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 17:18","pubTimestamp":1788772689,"startTime":"0","endTime":"0","summary":"智通财经APP讯，恒瑞医药(600276.SH)发布公告，近日，公司子公司山东盛迪医药有限公司收到国家药品监督管理局核准签发关于HRS-1597片的《药物临床试验批准通知书》，将于近期开展临床试验。HRS-1597片是公司自主研发的1类新药，拟用于体重管理。经查询，目前国内外暂无同类药物获批上市。截至目前，HRS-1597片相关项目累计研发投入约1690万元(未经审计)。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1492818.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","LU2289578879.USD","BK0028","LU1969619763.USD","LU2328871848.SGD","BK0060","LU1023057109.AUD","BK1191","BK0188","LU2580892862.HKD","LU2097828714.EUR","BK0196","LU2097828631.EUR","PSYK","LU1655091616.SGD","LU1064130708.USD","LU2097828474.EUR","LU2097828557.USD","BK0183","MDTX","LU1580142542.USD","LU1820825898.SGD","LU0359202008.SGD","LU0405327148.USD","LU1997245177.USD","LU0359201612.USD","LU1146622755.USD","LU2495084118.USD","LU1064131003.USD","LU1328615791.USD","LU1255011170.USD","LU1781817850.SGD","IBBJ","01276","LU2488822045.USD","LU2543165471.USD","BMED","LU2097828805.USD","LU0405327494.USD","600276","LU1997244956.HKD","LU1997245094.SGD","LU2148510915.USD","LU0359201885.HKD","LU2580892789.USD","IBBQ","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665313385","title":"智飛生物(300122.SZ)：重組輪狀病毒亞單位疫苗(大腸桿菌)獲得臨床試驗批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2665313385","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665313385?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 17:15","pubTimestamp":1788772542,"startTime":"0","endTime":"0","summary":"智通财经APP讯，智飞生物 发布公告，公司于近日获悉，由全资子公司北京智飞绿竹生物制药有限公司研发的重组轮状病毒亚单位疫苗获得国家药品监督管理局药物临床试验批准通知书，同意开展预防轮状病毒感染引起的急性胃肠炎的临床试验。公司的重组轮状病毒亚单位疫苗采用重组大肠杆菌发酵、纯化等工艺，获得三种基因型的重组VP8蛋白，经佐剂吸附制备成疫苗。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1492816.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IBBJ","MDTX","LU2148510915.USD","BK0239","BK0196","IBBQ","LU1064130708.USD","300122","BK0188","PSYK","BMED","LU1328615791.USD","LU2580892789.USD","BK0046","159646","BK0077","LU1064131003.USD","LU2580892862.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665831854","title":"恒瑞醫藥：子公司HRS-1597片獲臨床試驗批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2665831854","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665831854?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 16:47","pubTimestamp":1788770825,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IBBQ","MDTX","IBBJ","BMED","PSYK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665181063","title":"恒瑞醫藥：HRS-6209膠囊、HRS-4508片獲臨床試驗批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2665181063","media":"南方财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665181063?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 16:47","pubTimestamp":1788770820,"startTime":"0","endTime":"0","summary":"南财智讯9月7日电，恒瑞医药公告，HRS-6209胶囊、HRS-4508片收到国家药品监督管理局签发的《药物临床试验批准通知书》，同意开展临床试验。通知书明确：HRS-6209联合其他抗肿瘤治疗在晚期不可切除或转移性乳腺癌，或HRS-9813在晚期实体瘤患者中的安全性、耐受性、药代动力学及初步疗效的开放、多中心Ib/II期临床研究。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609073866721614.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609073866721614.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["IBBJ","LU2580892789.USD","LU1328615791.USD","LU2097828557.USD","LU2097828631.EUR","LU1064130708.USD","BK0060","600276","LU2148510915.USD","LU1580142542.USD","LU1820825898.SGD","LU1969619763.USD","BK0196","BK0188","LU1997244956.HKD","LU2543165471.USD","BK0183","LU0359201612.USD","LU1781817850.SGD","PSYK","LU2495084118.USD","BMED","BK0028","01276","LU2097828714.EUR","LU2289578879.USD","LU2097828805.USD","IBBQ","LU2328871848.SGD","BK1191","LU0359202008.SGD","LU0359201885.HKD","LU2488822045.USD","BK0239","LU1023057109.AUD","LU2580892862.HKD","LU1146622755.USD","BK0012","LU1997245177.USD","LU2097828474.EUR","LU1655091616.SGD","MDTX","LU1997245094.SGD","LU1064131003.USD","LU0405327148.USD","LU1255011170.USD","LU0405327494.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665550318","title":"華蘭疫苗(301207.SZ)：新型流感病毒mRNA疫苗臨床試驗獲批 目前國內尚無流感病毒mRNA疫苗產品獲批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2665550318","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665550318?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 16:42","pubTimestamp":1788770526,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华兰疫苗 发布公告，公司于近日收到国家药品监督管理局核准签发的关于新型流感病毒mRNA疫苗的《药物临床试验批准通知书》。公司研发的新型流感病毒mRNA疫苗采用mRNA技术路线，通过递送编码流感病毒相关抗原的mRNA，在体内表达相应抗原并诱导机体产生免疫应答。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1492774.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BMED","IBBJ","IPOS","301207","IBBQ","MRNY","BK0239","PSYK","MRNX","MDTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665318561","title":"華蘭疫苗(301207.SZ)：新型流感病毒mRNA疫苗臨床試驗獲批 目前國內尚無流感病毒mRNA疫苗產品獲批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2665318561","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665318561?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 16:42","pubTimestamp":1788770526,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IBBQ","MDTX","IPOS","MRNX","MRNY","IBBJ","PSYK","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665188143","title":"智飛生物：重組輪狀病毒亞單位疫苗獲臨床試驗批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2665188143","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665188143?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 16:38","pubTimestamp":1788770300,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IBBJ","BMED","MDTX","PSYK","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":11,"pageCount":10,"totalSize":215,"code":"91000000","status":"200"}]}}